Published January 1, 2013 | Version v1
Journal article

A Prospective, Multicenter Study of Complementary/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer

  • 1. Department of Radiation Therapy, William W. Backus Hospital, Norwich, Connecticut (United States)
  • 2. Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut (United States)
  • 3. Department of Epidemiology and Public Health, Yale University, New Haven, Connecticut (United States)
  • 4. University of Michigan, Department of Radiation Oncology, Ann Arbor, MI (United States)
  • 5. Yale University School of Medicine, New Haven, Connecticut (United States)
  • 6. Department of Radiation Therapy, Shoreline Medical Center, Guilford, Connecticut (United States)
  • 7. Department of Radiation Therapy, Lawrence and Memorial Hospital, New London, Connecticut (United States)

Description

Purpose: Although complementary and alternative medicine (CAM) utilization in breast cancer patients is reported to be high, there are few data on CAM practices in breast patients specifically during radiation. This prospective, multi-institutional study was conducted to define CAM utilization in breast cancer during definitive radiation. Materials/Methods: A validated CAM instrument with a self-skin assessment was administered to 360 Stage 0-III breast cancer patients from 5 centers during the last week of radiation. All data were analyzed to detect significant differences between users/nonusers. Results: CAM usage was reported in 54% of the study cohort (n=194/360). Of CAM users, 71% reported activity-based CAM (eg, Reiki, meditation), 26% topical CAM, and 45% oral CAM. Only 16% received advice/counseling from naturopathic/homeopathic/medical professionals before initiating CAM. CAM use significantly correlated with higher education level (P<.001), inversely correlated with concomitant hormone/radiation therapy use (P=.010), with a trend toward greater use in younger patients (P=.066). On multivariate analysis, level of education (OR: 6.821, 95% CI: 2.307-20.168, P<.001) and hormones/radiation therapy (OR: 0.573, 95% CI: 0.347-0.949, P=.031) independently predicted for CAM use. Significantly lower skin toxicity scores were reported in CAM users vs nonusers, respectively (mild: 34% vs 25%, severe: 17% vs 29%, P=.017). Conclusion: This is the first prospective study to assess CAM practices in breast patients during radiation, with definition of these practices as the first step for future investigation of CAM/radiation interactions. These results should alert radiation oncologists that a large percentage of breast cancer patients use CAM during radiation without disclosure or consideration for potential interactions, and should encourage increased awareness, communication, and documentation of CAM practices in patients undergoing radiation treatment for breast cancer.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2012.03.025

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2012.03.025;
PII
S0360-3016(12)00420-8;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
85
Journal Issue
1
Journal Page Range
p. 40-46
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
44104372
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
COMMUNICATIONS; EDUCATION; HORMONES; INTERACTIONS; MAMMARY GLANDS; MEDICAL PERSONNEL; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENTS; RADIOTHERAPY; SKIN; TOXICITY
Descriptors DEC
BODY; DISEASES; GLANDS; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PERSONNEL; RADIOLOGY; STATISTICS; THERAPY

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.